Fuji Research Park, Kyowa Hakko Kirin Co., Ltd, Suntou-gun, Shizuoka, Japan.
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3768-71. doi: 10.1016/j.bmcl.2010.04.058. Epub 2010 Apr 18.
Based on the previously reported lead compound, a series of benzofuran derivatives were prepared to study their antagonistic activities to A(2A) receptor. The replacement of the phenyl group at the 4-position with a heterocyclic ring improved the PK profile and aqueous solubility. From these studies, we discovered a potent new A(2A) antagonist, 12a, which has both a good oral bioavailability and in vivo efficacy on motor disability in MPTP-treated common marmosets.
基于先前报道的先导化合物,我们合成了一系列苯并呋喃衍生物,以研究它们对 A(2A)受体的拮抗活性。将 4-位的苯基用杂环取代可以改善 PK 性质和水溶解度。通过这些研究,我们发现了一种新型强效的 A(2A)拮抗剂 12a,它具有良好的口服生物利用度和在 MPTP 处理的普通狨猴运动障碍模型中的体内疗效。